[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-05-06 | Class II | LACTALIS CANADA, INCH-0680-2026 | Product may contain foreign objects, specifically glass. | Environmental Monitoring |
| 2026-05-06 | Class II | Medline Industries, LPZ-2008-2026 | During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin. | Environmental Monitoring |
| 2026-05-06 | Class II | Medline Industries, LPZ-2029-2026 | During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin. | Environmental Monitoring |
| 2026-05-06 | Class II | Medline Industries, LPZ-2018-2026 | During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin. | Environmental Monitoring |
| 2026-05-06 | Class II | Medline Industries, LPZ-2044-2026 | Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit. | Environmental Monitoring |
| 2026-04-29 | Class II | SurgiSmoke SolutionsZ-1925-2026 | Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1932-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1931-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1928-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | SurgiSmoke SolutionsZ-1926-2026 | Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape. | Environmental Monitoring |
| 2026-04-29 | Class II | B BRAUN MEDICAL INCD-0498-2026 | Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1930-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | SurgiSmoke SolutionsZ-1924-2026 | Certain lots of product were associated with a manufacturing nonconformance involving use of a non-gamma sterilization compatible drape. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1929-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | Remel Europe Ltd.Z-1923-2026 | Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype. | Environmental Monitoring |
| 2026-04-29 | Class II | B BRAUN MEDICAL INCD-0497-2026 | Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. | Environmental Monitoring |
| 2026-04-29 | Class II | B BRAUN MEDICAL INCD-0496-2026 | Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. | Environmental Monitoring |
| 2026-04-29 | Class II | LSL Healthcare Inc.Z-1933-2026 | Medical procedure kits were distributed containing Webcol Large Alcohol Prep Pads which were subsequently recalled for non-sterility. | Environmental Monitoring |
| 2026-04-29 | Class II | B BRAUN MEDICAL INCD-0495-2026 | Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. | Environmental Monitoring |
| 2026-04-29 | Class II | Harrow Eye LLCD-0489-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-04-29 | Class I | Unistel Industries Inc.H-0666-2026 | Product may be contaminated with Salmonella. | Environmental Monitoring |
| 2026-04-22 | Class II | Huons Co., Ltd.D-0529-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-04-22 | Class II | Owen Biosciences Inc.D-0453-2026 | Chemical contamination: Presence of benzene | Environmental Monitoring |
| 2026-04-22 | Class II | Owen Biosciences Inc.D-0454-2026 | Chemical contamination: Presence of benzene | Environmental Monitoring |
| 2026-04-22 | Class II | International Medication Systems Ltd.D-0483-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.